Facebook Instagram Linkedin Youtube
Home Tags Per Norlén

Tag: Per Norlén

Evaxion unveils genetic adjuvant technology to boost vaccines

Evaxion unveils genetic adjuvant technology to boost vaccines

Evaxion_Pantherna_POC

Evaxion and Pantherna reach preclinical proof-of-concept

Evaxion_FastTrack

Evaxion receives Fast Track for cancer vaccine candidate

Patent

Evaxion receives phase IIb go-ahead from FDA

Evaxion ExpreS2ion collaboration

Evaxion and ExpreS²ion to collaborate on CMV vaccine

Evaxion new strategic focus

Evaxion comments on new strategic focus

Per Norlén, CEO Evaxion

Evaxion brings in Per Norlén as CEO

Leading

Targinta takes lead in the ADC field in the Nordics

Targinta

Targinta’s CEO comments on preclinical data in TNBC and the spin-out

Xintela

Xintela advances to clinical phase in OA and difficult-to-heal wounds in...

12Page 1 of 2
© BioStock 2025